When viral DNA is more “liquidy,” it is more easily injected into host cells—so easily, in fact, that multiple virus-carrying capsids may squeeze their DNA payloads into a host cell simultaneously.

Phase I clinical and pharmacokinetic (PK) trial of the kinesin spindle protein (KSP) inhibitor MK-0731 in cancer patients No significant financial relationships to disclose. This is an ASCO Meeting ...

Lytic viral infection and programmed cell death (PCD) are thought to represent two distinct death mechanisms in phytoplankton, unicellular photoautotrophs that drift with ocean currents. Here, we ...

The oncogenic herpesvirus (HHV8 or KSHV) causes a cancer known as Kaposi's Sarcoma. An international team of scientists led by the University of Helsinki has discovered key factors that control the ...

A new study reveals how C210, a curcumin derivative, selectively reactivates Epstein–Barr virus to kill cancer cells without infectious risks, paving the way for safer, targeted cancer therapies.

When viruses infect cells, changes in the cell nucleus occur, and these can be observed through fluorescence microscopy. Using fluorescence images from live cells, researchers have trained an ...

EBV is strongly associated with MS, potentially acting as a necessary trigger for the disease. The "driver hypothesis" suggests ongoing EBV replication drives MS activity. Observations in HIV-positive ...